True Private Wealth Advisors Astrazeneca PLC Transaction History

True Private Wealth Advisors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$66.81 - $80.83 $184,061 - $222,686	2,755 New	2,755 $214,000
Q4 2023 Jan 30, 2024	SELL	$61.89 - $69.28 $35,277 - $39,489	-570 Reduced 15.75%	3,049 $205,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $234,692 - $259,482	3,619 New	3,619 $245,000
Q1 2021 May 12, 2021	SELL	$47.16 - $54.44 $80,172 - $92,548	-1,700 Closed	0 $0
Q3 2020 Oct 09, 2020	BUY	$53.07 - $61.1 $5,307 - $6,110	100 Added 6.25%	1,700 $93,000
Q4 2019 Jan 27, 2020	BUY	$42.46 - $50.46 $67,936 - $80,736	1,600 New	1,600 $79,000
Q3 2019 Oct 09, 2019	SELL	$40.12 - $45.47 $235,905 - $267,363	-5,880 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$37.28 - $41.68 $59,908 - $66,979	-1,607 Reduced 21.46%	5,880 $242,000
Q1 2019 Apr 25, 2019	BUY	$35.49 - $43.02 $52,099 - $63,153	1,468 Added 24.39%	7,487 $302,000
Q4 2018 Jan 14, 2019	BUY	$36.86 - $41.49 $16,476 - $18,546	447 Added 8.02%	6,019 $228,000
Q3 2018 Oct 18, 2018	SELL	$34.76 - $39.72 $63,749 - $72,846	-1,834 Reduced 24.76%	5,572 $0
Q2 2018 Jul 13, 2018	BUY	$34.55 - $37.05 $255,877 - $274,392	7,406 New	7,406 $260,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.